PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
59.76
ESG score 90-95% of TGTX's 64.09. Bill Ackman would demand clear ESG improvement catalysts.
59.57
Environmental score 1.1-1.2x TGTX's 50.00. Guy Spier would verify if superior environmental practices translate to better regulatory positioning.
59.91
Social score below 80% of TGTX's 84.93. Jim Chanos would check for potential social license and litigation risks.
59.79
Similar governance score to TGTX's 57.35. Bruce Berkowitz would investigate if industry governance norms adequately protect shareholder value.